Categories:

Update RSNA - Neuroradiology

01/10 to 01/11/2025

Seminar in Radiological Diagnostics: "RSNA Update – Neuroradiology"

Project RACOON-RESCUE: Advancing Diagnosis and Treatment for Pediatric Non-Hodgkin Lymphoma

Pediatric Non-Hodgkin Lymphoma (NHL), a type of lymph node cancer, is the fourth most common tumor in children and adolescents. Radiological…

RSNA 2024

12/01 to 12/04/2024 Chicago, IL

Annual Meeting of the Radiological Society of North America

Screenshot of a prostate lesion in mint Lesion

Streamline Prostate Cancer Screenings with Prostate.Carcinoma.ai in mint Lesion

The Prostate.Carcinoma.ai plug-in, developed by our partner FUSE-AI, is a powerful addition to mint Lesion, designed specifically to enhance prostate…

Image of a female doctor holding a hologram of a lung

Structured Reporting Improves TNM Classification Accuracy and Radiologist Satisfaction

In a collaborative, multi-center study, radiology experts developed and validated in mint Lesion a software-assisted structured reporting (SR)…

Screenshot of structured reading template for NSCLC Staging

Software-Assisted Structured Reporting Improves TNM Classification Accuracy in NSCLC Staging

In this multi-center collaboration, thoracic radiology experts developed and evaluated a software-assisted structured reporting (SR) framework for…

AI lung nodules detection in contextflow and Lung-RADS in mint Lesion

Leverage Advanced AI-Driven Nodule Detection and Analysis for Comprehensive Patient Care

Discover the power of streamlined AI-driven lung screening with contextflow ADVANCE Chest CT integrated into mint Lesion. With automated lung nodule…

Hands holding a glass lung

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing…

Image shows graphic related to study's research on iRECIST and RECIST

University Hospital Cologne: Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

A retrospective study conducted at University Hospital Cologne compared two criteria for assessing therapeutic response to immunotherapy: iRECIST and…